These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1513578)

  • 1. Effect of heparin surface modification of polymethylmethacrylate intraocular lenses on signs of postoperative inflammation after extracapsular cataract extraction. One-year results of a double-masked multicenter study.
    Borgioli M; Coster DJ; Fan RF; Henderson J; Jacobi KW; Kirkby GR; Lai YK; Menezo JL; Montard M; Strobel J
    Ophthalmology; 1992 Aug; 99(8):1248-54; discussion 1254-5. PubMed ID: 1513578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of heparin-surface-modified poly(methyl methacrylate) intraocular lenses on the postoperative inflammation in an Asian population.
    Lai YK; Fan RF
    J Cataract Refract Surg; 1996; 22 Suppl 1():830-4. PubMed ID: 9279680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of heparin-surface-modified intraocular lenses on postoperative inflammation after phacoemulsification: a randomized trial in a United States patient population. Heparin-Surface-Modified Lens Study Group.
    Trocme SD; Li H
    Ophthalmology; 2000 Jun; 107(6):1031-7. PubMed ID: 10857818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cellular response one year after extracapsular cataract extraction--comparison of regular and heparin surface modified PMMA intraocular lenses].
    Petrus M; Czajkowski G
    Klin Oczna; 2000; 102(3):165-8. PubMed ID: 11126169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of posterior capsule opacification in eyes with exfoliation syndrome and heparin-surface-modified intraocular lenses.
    Zetterström C
    J Cataract Refract Surg; 1993 May; 19(3):344-7. PubMed ID: 8501628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin surface modified intraocular lenses. Three-month follow-up of a randomized, double-masked clinical trial.
    Philipson B; Fagerholm P; Calel B; Grunge A
    J Cataract Refract Surg; 1992 Jan; 18(1):71-8. PubMed ID: 1735865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective analysis of heparin-surface-modified intraocular lenses versus regular polymethylmethacrylate intraocular lenses in patients with uveitis.
    Lardenoye CW; van der Lelij A; Berendschot TT; Rothova A
    Doc Ophthalmol; 1996-1997; 92(1):41-50. PubMed ID: 9181331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin surface-modified intraocular lenses in patients with inactive uveitis or diabetes.
    Tabbara KF; Al-Kaff AS; Al-Rajhi AA; Al-Mansouri SM; Badr IA; Chavis PS; Al-Omar OM
    Ophthalmology; 1998 May; 105(5):843-5. PubMed ID: 9593384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exfoliation syndrome and heparin surface modified intraocular lenses.
    Zetterström C; Lundvall A; Olivestedt G
    Acta Ophthalmol (Copenh); 1992 Feb; 70(1):91-5. PubMed ID: 1557981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin surface modified intraocular lenses--a one-year follow-up of a safety study.
    Philipson B; Fagerholm P; Calel B; Grunge A; Hallnäs K; Lydahl E; Ohman L
    Acta Ophthalmol (Copenh); 1990 Oct; 68(5):601-3. PubMed ID: 2275360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-surface-modified intraocular lens implantation in patients with glaucoma, diabetes, or uveitis.
    Lin CL; Wang AG; Chou JC; Shieh G; Liu JH
    J Cataract Refract Surg; 1994 Sep; 20(5):550-3. PubMed ID: 7996412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of cellular foreign body reactions to lens implants].
    Wenzel M; Ygge J
    Fortschr Ophthalmol; 1991; 88(2):132-4. PubMed ID: 1855729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinous reaction on implanted intraocular lenses. A comparison of conventional PMMA and heparin surface modified lenses.
    Lundgren B; Selén G; Spångberg M; Härfstrand A
    J Cataract Refract Surg; 1992 May; 18(3):236-9. PubMed ID: 1593429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results and biocompatibility of heparin-surface-modified intraocular lenses.
    Amon M; Menapace R
    J Cataract Refract Surg; 1993 Mar; 19(2):258-62. PubMed ID: 8487171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinous uveitis and intraocular lens implantation. Surface modification of polymethylmethacrylate during extracapsular cataract surgery.
    Rose GE
    Ophthalmology; 1992 Aug; 99(8):1242-7. PubMed ID: 1513577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between aqueous flare and cells and lens surface cytology in eyes with poly(methyl methacrylate) and heparin-surface-modified intraocular lenses.
    Pande M; Shah SM; Spalton DJ
    J Cataract Refract Surg; 1995 May; 21(3):326-30. PubMed ID: 7674172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo study of cell reactions on poly(methyl methacrylate) intraocular lenses with different surface properties.
    Amon M; Menapace R; Radax U; Freyler H
    J Cataract Refract Surg; 1996; 22 Suppl 1():825-9. PubMed ID: 9279679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heparin-surface-modified PMMA intraocular lenses in children in early and late follow-up].
    Koraszewska-Matuszewska B; Samochowiec-Donocik E; Pieczara E; Filipek E
    Klin Oczna; 2003; 105(5):273-6. PubMed ID: 14746178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular reaction on the anterior surface of poly(methyl methacrylate) intraocular lenses.
    Pande MV; Spalton DJ; Kerr-Muir MG; Marshall J
    J Cataract Refract Surg; 1996; 22 Suppl 1():811-7. PubMed ID: 9279677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Capsular sack implantation of heparin-modified posterior chamber lenses].
    Steinkogler FJ; Huber-Spitzy V; Arocker-Mettinger E; Huber E
    Klin Monbl Augenheilkd; 1991 Jan; 198(1):6-8. PubMed ID: 2023379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.